Drug intelligence / Profile preview

Lisosan G

Development stage
Phase 4
Lead developer
Agrisan
Administration
Oral
01

Overview

Lisosan G is a nutritional supplement registered with the Italian Ministry of Health, provided by Agrisan Company. It is a fermented powder derived from organic whole grains of Triticum aestivum (wheat). The fermentation process enriches the powder with a variety of bioactive metabolites, including polyphenols, alpha-lipoic acid, vitamins, and polyunsaturated fatty acids, which contribute to its antioxidant and anti-inflammatory properties. Research has explored its potential protective effects across several conditions. Its mechanism is believed to involve the reduction of oxidative stress and inflammation through pathways such as inhibiting NF-κB signaling, reducing levels of inflammatory markers like VEGF, ICAM-1, IL-6, and ET-1, and scavenging reactive oxygen species. A recent clinical study also showed it can attenuate GLP-1 concentrations to reduce post-bariatric hypoglycemia.

Brand names
Lisosan-G
Other names
Lisosan G
02

Targets

HMOX1 (Heme oxygenase 1)ICAM1 (Intercellular Adhesion Molecule 1)ET-1 (Endothelin-1)GLP-1 (Glucagon-like peptide-1)IL-6 (Interleukin 6)NF-κBVEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on Lisosan G.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lisosan G.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call